scholarly article | Q13442814 |
P50 | author | Rosalind Eeles | Q24640445 |
Gianluca Severi | Q28360445 | ||
Graham Giles | Q30524411 | ||
Dallas R. English | Q40580176 | ||
Zsofia Kote-Jarai | Q42576837 | ||
Nicholas Van As | Q42863745 | ||
Robert J MacInnis | Q44277751 | ||
John Hopper | Q56726496 | ||
Ali Amin Al Olama | Q57565560 | ||
Douglas F. Easton | Q59812154 | ||
Michelle Guy | Q59832092 | ||
Lesley McGuffog | Q63233438 | ||
Antonis C Antoniou | Q89766295 | ||
David P Dearnaley | Q92184115 | ||
Robert Huddart | Q94521114 | ||
Margaret R E McCredie | Q114292608 | ||
Vincent Khoo | Q114365957 | ||
Alan Horwich | Q114365958 | ||
Lynne T O'Brien | Q114367560 | ||
Emma J Sawyer | Q114367561 | ||
Audrey T. Ardern-Jones | Q114387262 | ||
P2093 | author name string | Christopher C Parker | |
Rosemary A Wilkinson | |||
Amanda L Hall | |||
P2860 | cites work | Mortality results from a randomized prostate-cancer screening trial | Q24601536 |
A new look at the statistical model identification | Q26778401 | ||
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer | Q28943505 | ||
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study | Q29417022 | ||
Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium | Q30491647 | ||
An approximate model of polygenic inheritance | Q33971299 | ||
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene | Q34354479 | ||
Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
A systematic review and meta-analysis of familial prostate cancer risk | Q35142714 | ||
Risk prediction models for familial breast cancer | Q36430753 | ||
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer | Q36611191 | ||
Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype | Q36614710 | ||
Prostate cancer genomics: towards a new understanding | Q37292004 | ||
Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. | Q38426753 | ||
Cancer risk prediction models: a workshop on development, evaluation, and application | Q44065523 | ||
Multiple loci on 8q24 associated with prostate cancer susceptibility. | Q50582715 | ||
The finite polygenic mixed model: An alternative formulation for the mixed model of inheritance. | Q52374131 | ||
Genome-wide association studies in cancer. | Q53316917 | ||
Two variants on chromosome 17 confer prostate cancer risk and the one in TCF2 protects against type 2 diabetes | Q56968912 | ||
Smoking and prostate cancer: Findings from an Australian case-control study | Q56995007 | ||
Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies | Q57265692 | ||
Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers | Q58143504 | ||
Programs for pedigree analysis: Mendel, Fisher, and dGene | Q59760870 | ||
Polygenic inheritance of breast cancer: Implications for design of association studies | Q79162761 | ||
Cumulative association of five genetic variants with prostate cancer | Q80503113 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 549-556 | |
P577 | publication date | 2011-07-18 | |
P1433 | published in | Genetic Epidemiology | Q5532864 |
P1476 | title | A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact | |
P478 | volume | 35 |
Q36959139 | A personalised approach to prostate cancer screening based on genotyping of risk founder alleles |
Q34265269 | A review of cancer risk prediction models with genetic variants |
Q48515655 | A review of prostate cancer genome wide association studies (GWAS). |
Q35848518 | A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects |
Q37623732 | Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease |
Q37138670 | Association between 17q25.3-rs6465657 polymorphism and prostate cancer susceptibility: a meta-analysis based on 19 studies |
Q37474443 | Biomarkers for prostate cancer: present challenges and future opportunities |
Q37148139 | Biomarkers in prostate cancer epidemiology |
Q37002946 | Cancer Prevention: Obstacles, Challenges and the Road Ahead. |
Q33863654 | Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance |
Q36394012 | Diffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk. |
Q36388749 | Evaluating genetic risk for prostate cancer among Japanese and Latinos |
Q37650650 | Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease |
Q35949522 | Germline BRCA1 mutations increase prostate cancer risk |
Q37474516 | Germline genetic profiling in prostate cancer: latest developments and potential clinical applications. |
Q35146870 | Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing |
Q29417155 | Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array |
Q47994728 | Improving Disease Prediction by Incorporating Family Disease History in Risk Prediction Models with Large-Scale Genetic Data |
Q37378034 | Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model |
Q27001297 | Inherited susceptibility for aggressive prostate cancer |
Q54938332 | MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project. |
Q53423427 | Men with a susceptibility to prostate cancer and the role of genetic based screening. |
Q38596777 | Multigene panels in prostate cancer risk assessment: a systematic review |
Q35646703 | Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans |
Q36543050 | Personalized medicine and access to health care: potential for inequitable access? |
Q37541989 | Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes |
Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
Q64137885 | Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test |
Q36356727 | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q37541290 | Prediction of prostate cancer from prostate biopsy in Chinese men using a genetic score derived from 24 prostate cancer risk-associated SNPs |
Q50175857 | Prostate Cancer Germline Variations and Implications for Screening and Treatment. |
Q34944738 | Prostate cancer risk prediction based on complete prostate cancer family history |
Q46777345 | Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men. |
Q35815958 | Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci |
Q37963657 | Risk-based prostate cancer screening. |
Q37017011 | The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer |
Q38168060 | The genetic epidemiology of prostate cancer and its clinical implications |
Q27025062 | The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making |
Q37633573 | Using information of relatives in genomic prediction to apply effective stratified medicine. |
Search more.